My SciELO
Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Española de Sanidad Penitenciaria
On-line version ISSN 2013-6463Print version ISSN 1575-0620
Abstract
GODOY, P. Guidelines on controlling latent tuberculosis infection to support tuberculosis elimination. Rev. esp. sanid. penit. [online]. 2021, vol.23, n.1, pp.28-36. Epub Apr 12, 2021. ISSN 2013-6463. https://dx.doi.org/10.18176/resp.00028.
Objectives
Latent TB infection (LTBI) affects 25% of the world's population. As long as this reservoir exists, the elimination of TB will not be feasible. The Assembly of the World Health Organization adopted the “Global End TB” strategy for the elimination of TB in 2014. The objective of this review is to present strategies for risk groups that are candidates for the detection and treatment of LTBI.
Material and method
There is sufficient evidence of screening in: immunocompromised people (HIV-infected, biological therapies, alternative renal therapy, organ transplantation), recent immigrants, inmates in prison, people injecting drugs and homeless people, and workers from at-risk settings. Tests to diagnose LTBI include tuberculin skin test (TST) and gamma release assay interferon (IGRA). There is no reference test and the choice of one or the other will depend on logistical considerations, such as avoiding injection (TST) or not needing a second visit (IGRA). Treatment of LTBI is based on the use of isoniazide and rifampicin in short period of 3 or 4 months, using associations of rifampicin and isoniazide or rifampicin alone.
Discussion
Given the estimated high prevalence of LTBI, renewed efforts are required to reduce the number of people with LTBI that includes a registration and monitoring system to observer progress, increased testing, and the use of short treatment guidelines.
Keywords : latent tuberculosis infection; tuberculosis; tuberculin test; interferon-gamma.